Can we make cancer immunotherapy work for more people?
One of the most exciting advances in cancer treatment over the last decade has been immunotherapy, which uses the body's own immune system to recognise and attack cancer cells.
Read moreReflections from the BTRU Annual Meeting 2026
Read moreSpotlight on Wei-Che Chang
Read moreUncovering New Mechanisms in Immune Cancer Defence
Read morePartners in Research: Sharing lessons from the PRO‑CAR‑T™ Study
Read moreDirector
OUR MISSION
Our programme seeks not only to accelerate translation of novel cellular therapies into the clinic, but also to increase their accessibility.
We want to better understand the impact of these new technologies from the patient perspective.
Professor Ronjon Chakraverty
NIHR BTRU Precision Cellular Therapeutics Lead
Our research
Theme 1: Precision T Cell Therapies for Leukaemia
THEME 2: Graft Manipulation and gene editing
Theme 3: Access and Patient-Reported Outcomes
Bite-sized BTRU
A series of posters demystifying the science behind our work.
Making CAR T cell therapy safer
T Cell Differentiation
Making new neutrophils
Get Involved
PATIENT & PUBLIC INVOLVEMENT & ENGAGEMENT
Advanced Cellular Therapeutics Academy
